Studies of American and Swiss scholarships, which were published in the journal Nature, indicate that people with SARS in 2003 were immune to coronavirus.

Studies suggest that antibodies produced by such people can be used to prevent coronavirus in people at high risk of infection.

According to the latest WHO data, more than 4.6 million cases of infection have been recorded in the world COVID - 19.